RxDoctor Payments Data

Nicholas Southard, DO

Vascular Surgery · West Des Moines, IANPI 1124281902

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,000 of the $26,754 with a category attached, or 82.2%. Medtronic accounts for 90.2% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $11,808 and has fallen 63.9% since, to $4,263 in 2025.

$26,754in general payments, 2019–2025

Across 113 payments — averaging $236.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$24K
  • W. L. Gore & Associates, Inc.$439
  • Inari Medical, Inc.$351
  • Endologix LLC$329
  • Abbott$259
  • Silk Road Medical, Inc.$189
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$22,00082%
  • Food & beverage$4,74118%
  • Education$130%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,754 in reported general payments places this provider in the 85th percentile of 38 vascular surgery providers in Iowa.

See all vascular surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$659,402
Medicare patients
1,335
Services billed
2,882

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban69$55,227
EliquisApixaban29$17,526
ClopidogrelClopidogrel Bisulfate534$2,830
Cilostazol32$261
Atorvastatin Calcium22$63
Prednisone11$19

Paid to pharmacies, not to this prescriber.

Other vascular surgery in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →